Trifecta Achievement in Open and Laparoscopic Partial Nephrectomy
NCT ID: NCT06960135
Last Updated: 2025-05-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
70 participants
INTERVENTIONAL
2022-06-01
2025-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objectives: this study pointing to determine trifecta outcomes of OPN and LPN and to identify predictive factors for trifecta achievement to evaluate surgical performance, including negative surgical margins, absence of severe surgical complications, and Ischemia time less than 25 Minutes.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Comparative Study Between Anterior and Posterior Pyelotomy in Transperitoneal Laparoscopic Pyelolithotomy
NCT06394219
Comparison of Oblique Subcostal, Posterior or Dual Transversus Abdominis Plane Block in Laparoscopic Cholecystectomy
NCT04693156
The Comparison of Single Incision Laparoscopic Appendectomy and Three Port Laparoscopic Appendectomy
NCT01816568
Evaluation of Risk Factors Leading to Conversion From Laparoscopic Cholecystectomy to Open Surgery
NCT06244589
Oxidative Stress in Standard Laparoscopic vs Single Port Cholecystectomy
NCT01211743
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
open partial nephrectomy
open partial nephrectomy
open partial nephrectomy
open partial nephrectomy
laparoscopic partial nephrectomy
laparoscopic partial nephrectomy
laparoscopic partial nephrectomy
laparoscopic partial nephrectomy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
open partial nephrectomy
open partial nephrectomy
laparoscopic partial nephrectomy
laparoscopic partial nephrectomy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with renal tumor who are indicated for partial nephrectomy
Absolute:
1. Solitary kidney.
2. Bilateral renal tumor.
3. CDK.
Relative:
1. Abnormal contralateral kidney (nephropathy, nephrolithiasis, trauma).
2. Metabolic disease associated with renal failure (DM, hypertension).
3. Genetic syndrome with tumor multifocality (VHL syndrome). Elective
1\. Clinical T1N0M0 Tumor. 2. Peripheral tumor.
Exclusion Criteria
* Patients who are contraindicated for partial nephrectomy. As severe and irreversible coagulopathy. Patients who are indicated for radical nephrectomy (extensive tumor, metastatic tumor).
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
South Valley University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Omar Ahmad Bakheet
Assistant Lecturer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
SVU hospital
Qena, Egypt, Qena Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SVU-MED-URO016-2-22-5-400
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.